Rigel Pharmaceuticals
RIGL
RIGL
131 hedge funds and large institutions have $400M invested in Rigel Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 39 increasing their positions, 29 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0.21% less ownership
Funds ownership: 9.52% → 9.31% (-0.21%)
6% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 17
2% less funds holding
Funds holding: 133 → 131 (-2)
Holders
131
Holding in Top 10
1
Calls
$916K
Puts
$335K
Top Buyers
| 1 | +$4.12M | |
| 2 | +$2.37M | |
| 3 | +$2.08M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.67M |
| 5 |
Renaissance Technologies
New York
|
+$1.6M |
Top Sellers
| 1 | -$7.78M | |
| 2 | -$7.32M | |
| 3 | -$4.97M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$2.96M |
| 5 |
Morgan Stanley
New York
|
-$2.42M |